November 19, 2026 | Patient Safety, Wellness

In July, Newsweek published “Peptides Are the New Longevity Craze. Safety Data Tells a Different Story” by Melissa Fleur Afshar. The reporter asked me for a surgeon’s view. The piece ran without it.
The full version, category by category, is on Southwest Plastic Surgery. This is the surgical version, and it is shorter, because for a surgeon the safety question collapses to one thing: what is in the vial, and who can tell me.
What the Data Says, in One Line
Newsweek’s bluntest source was Mansoor Amiji, a professor of pharmaceutical sciences at Northeastern: “Except for GLP-1 agonists by Eli Lilly and Novo, and other FDA-approved peptides, there are no preclinical or clinical studies showing safety and effectiveness of these ‘hyped’ peptides.”
I told the reporter the same thing from the other direction:
“Peptides that are compounded or injected are promising enough to merit genuine study, and they are already used a great deal, far ahead of the studies and with almost no supervision.”
Promising and unsupervised is a bad combination on an operating table.
What Unsupervised Looks Like in My Clinic
“It is about impossible to go a month without seeing at least one patient who is self-injecting peptides obtained without a prescription from who knows where, for an injury, for joint pain, or for what they are calling “recovery.””
“I have seen and operated on patients with abscesses as well as infected lesions at injection sites that stem from these supplies.”
One of those cases, as I described it for MDLinx in September:
“Yes, I’ve had a patient, a male in his 30s, who was self-administering the Wolverine stack, which he purchased on the internet. He came in with a red area in the buttock, with fevers and night sweats. When we examined him, he had an area that was boggy. We went ahead and lanced it and removed purulent discharge, and we started packing it for about a week, with antibiotics. The cultures came back as Staph aureus.”
That is my safety data. It is not a trial. It is a drain, a culture and a week of packing, and the common thread in every case has been the source.
The Question I Ask Before Every Operation
“I am now asking my patients about peptide use before surgery exactly how I would ask them about supplements. When it comes from an online research chemical supplier, neither the patient nor I knows what is inside the bottle.”
Here is why that matters in surgical terms.
| What I need to know | Why a surgeon cares |
|---|---|
| What you are injecting | An unknown compound is an unknown interaction with anesthesia and with healing |
| Where it came from | A licensed pharmacy gives me a verified dose and a sterile product; an online vial gives me neither |
| Where you inject it | Nodules and old injection sites can sit exactly where I plan to make an incision or place a graft |
| When you last used it | Some compounds I want stopped before surgery, the way I stop certain supplements |
If you cannot answer the first two, the honest plan is to stop, let the sites settle, and reschedule. I would rather move a surgery date than operate through a question mark.
What the FDA Decision Changes for a Surgical Patient
Newsweek built its story around the FDA advisory committee meeting of July 23 on compounding previously banned peptides. For a patient, the only change that matters is the label.
“A compounded product from a 503A or 503B pharmacy is made under FDA-regulated conditions, sterility-tested, and labeled with a verified dose and purity.”
“Allowing a pharmacy to compound it means a pharmacy can make it. Allowing them to make it does not mean it will work.”
A verified dose answers my question as a surgeon. It does not answer the researchers’ question about whether the peptide does anything, and I tell patients both halves.
How We Do It Here
When a patient of mine wants a peptide protocol, it runs through the Med Spa, not a storefront:
“Patients are referred for comprehensive baseline laboratory testing prior to initiating therapy. Baseline laboratory evaluations include assessment of liver and kidney function through a CMP.”
Labs first, a licensed pharmacy, a provider who sees you monthly. The protocol post covers the monitoring, and the vial check post covers what I look for on a label. The shorter commentary on why the regulators and the researchers are both right is on Dr. WorldWide.
Why Choose Dr. Agullo
I am certified by the American Board of Plastic Surgery and the American Board of Surgery, completed my plastic surgery fellowship at the Mayo Clinic, and serve as Clinical Associate Professor of Plastic Surgery at Texas Tech University Health Sciences Center. I sit on the editorial boards of Aesthetic Plastic Surgery and Plastic and Reconstructive Surgery Global Open, and Castle Connolly has listed me as a Top Doctor every year from 2014 through 2026. I ask about peptides before surgery because I have drained what happens when nobody did.
Ready to Talk?
Bring the vial to your consultation, labeled or not. Call (915) 590-7900, text 1-866-814-0038, or book online at agulloplasticsurgery.com/appointments. #StayBeautiful
Find me at @RealDrWorldWide on Instagram, TikTok, and Snapchat, @Agullo on X, or @AgulloPlasticSurgery on Facebook.



